Key points are not available for this paper at this time.
From the safety/ quality point of view, NS lack of harmonisation and sovereign laws/ institutional controls on the market and their wide commercialization may possibly lead to risks to public health.
Kioukia‐Fougia et al. (Wed,) studied this question.